Filing Flows › Elite Pharmaceuticals (ELTP) › Recalls, complaints & regulation
Elite Pharmaceuticals (ELTP): recalls
Elite Pharmaceuticals (ELTP) beyond its filings: 0 recalls in the last 12 months (1 in five years, 0 Class I).
Latest recalls
- 2022-04-21 · CPSC · Elite Comfort Solutions Recalls Nectar® Premier Mattresses Due to Failure to Meet Federal Flammability Standard; Sold Exclusively at NectarSleep.com (Recall Alert)
Elite Pharmaceuticals' latest quarter
Elite Pharmaceuticals, Q1 FY27: revenue $32.4M (-20% year over year), operating margin 23.3%, net earnings $5.9M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
Questions
Has Elite Pharmaceuticals had any recalls?
1 recall on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.